Corvus Pharmaceuticals (CRVS) Return on Assets (2023 - 2025)
Historic Return on Assets for Corvus Pharmaceuticals (CRVS) over the last 3 years, with Q3 2025 value amounting to 0.02%.
Historic Return on Assets for Corvus Pharmaceuticals (CRVS) over the last 3 years, with Q3 2025 value amounting to 0.02%.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month